Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma

Mireille M Hermans, Corstiaan C Breugem, Renske Schappin, Emma Jonge Poerink, Elodie J Mendels, Aviël Ragamin, Johannes M P J Breur, Hester R Langeveld, Martine F Raphael, Peter C J De Laat, Saskia N De Wildt, André B Rietman, Suzanne G M A Pasmans, Marlies De Graaf

Research output: Contribution to journalArticleAcademicpeer-review

21 Downloads (Pure)

Abstract

Infantile haemangiomas are common benign tumours of infancy, which can be treated effectively with beta-blockers such as propranolol and atenolol. Different types of beta-blockers may result in different long-term aesthetic outcomes. This study evaluated the difference in long-term aesthetic outcomes between infantile haemangiomas treated with either propranolol or atenolol, including the perspective of physicians, parents, and children. Children, aged ≥6 years, treated with propranolol or atenolol for infantile haemangioma during infancy, participated in this 2-centre cross-sectional study. The primary endpoint was change in appearance of the infantile haemangioma from pre-treatment to follow-up, using a physician-rated visual analogue scale (VAS). Secondary outcomes were the Patient Observer Scar Assessment Scale (physician- and parent-rated) and a VAS (child-rated), assessing the residual lesion. In total, 103 children (35 treated with propranolol, 68 with atenolol) were analysed. No differences were found between children treated with propranolol and children treated with atenolol on physician-rated VAS (p = 0.10) or any secondary outcomes. Physicians indicated a large aesthetic improvement from pre-treatment to follow-up. Physicians, parents and children were positive about the current state of the residual lesion. Minor sequelae were common (86%). These results, in combination with the favourable safety profile of atenolol, should be considered when choosing beta-blocker treatment for infantile haemangioma.

Original languageEnglish
Article numberadv00788
JournalActa Dermato-Venereologica
Volume102
Early online date4 May 2022
DOIs
Publication statusPublished - 11 Oct 2022

Keywords

  • adrenergic beta-antagonist
  • capillary hemangioma
  • cicatrix
  • esthetics
  • vascular malformation
  • vascular tissue neoplasm

Fingerprint

Dive into the research topics of 'Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma'. Together they form a unique fingerprint.

Cite this